The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study
Abstract
AIMS: Mounting evidence suggests infection, specifically Chlamydia pneumoniae, plays a role in atherosclerosis. We tested whether antibiotic treatment with the macrolide roxithromycin improves clinical outcome in patients with acute non-Q-wave coronary syndromes. Preliminary reports revealed a reduction in events in the roxithromycin group at 30 days. We now report the long-term follow-up results. METHODS AND RESULTS: Sixty-four per cent of the initial 202 patients with unstable angina who were randomly assigned to receive either roxithromycin or placebo for 30 days completed the active treatment period. At day 30, the primary triple and double end-point rates were 9% and 4% in the placebo group compared to 2% and 0% in the roxithromycin group (unadjusted P = 0.032 and 0.058, respectively). The secondary triple and double end-point rates were again higher in the placebo group at day 90 (12.5% and 6.25% vs 4.37% and 0%, unadjusted P = 0.065 and 0.029, respectively), and at day 180 (14.6% and 7.29% vs 8.69% and 2.17%, unadjusted P = 0.259 and 0.17, respectively). Anti-C, pneumoniae IgG titres were unchanged in both groups while C-reactive protein levels decreased in both strategies, with a more significant decrease in the roxithromycin arm (P = 0.03). Elevated C-reactive protein levels predicted the need for revascularization. CONCLUSIONS: In this pilot trial, roxithromycin appears to extend the clinical benefit of preventing death and re-infarction for at least 6 months after initial treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,424
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Gupta, S., Leatham, E. W., Carrington, D., Mendall, M. A., Kaski, J. C., & Camm, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.2.404 · Cited by 706
Patel, P., Mendall, M. A., Carrington, D., Strachan, D. P., Leatham, E., Molineaux, N., Levy, J., Blakeston, C., Seymour, C. A., Camm, A. J., et al. (1995) · BMJ · doi:10.1136/bmj.311.7007.711 · Cited by 592
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
Gurfinkel, E., Bozovich, G., Daroca, A., Beck, E., & Mautner, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07201-2 · Cited by 573
Self-citationLibby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Muhlestein, J. B., Anderson, J. L., Hammond, E. H., Zhao, L., Trehan, S., Schwobe, E. P., & Carlquist, J. F. (1998) · Circulation · doi:10.1161/01.cir.97.7.633 · Cited by 517
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
Muhlestein, J. B., Hammond, E. H., Carlquist, J. F., Radicke, E., Thomson, M. J., Karagounis, L. A., Woods, M. L., & Anderson, J. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00055-1 · Cited by 420
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.
Schett, G., Xu, Q., Amberger, A., Van der Zee, R., Recheis, H., Willeit, J., & Wick, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118320 · Cited by 288
Linnanmäki, E., Leinonen, M., Mattila, K., Nieminen, M. S., Valtonen, V, & Saikku, P. (1993) · Circulation · doi:10.1161/01.cir.87.4.1130 · Cited by 283
Rabbit model for Chlamydia pneumoniae infection
Fong, I. W., Chiu, B., Viira, E., Fong, M. W., Jang, D., & Mahony, J. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.48-52.1997 · Cited by 258
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus
Epstein, S., Speir, E. H., Zhou, Y., Guetta, E., Leon, M. B., & Finkel, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98005-8 · Cited by 158
Chronic infection and coronary artery disease
Muhlestein, J. B., & Anderson, J. L. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00054-7 · Cited by 80
Epitope Specificity of Anti–Heat Shock Protein 65/60 Serum Antibodies in Atherosclerosis
Metzler, B., Schett, G. A., Kleindienst, R., van der Zee, R., Ottenhoff, T. H. M., Hajeer, A. H., Bernstein, R. M., Xu, Q., & Wick, G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.3.536 · Cited by 78
Chronic infections and coronary heart disease
Ånestad, G., Scheel, O., & Hungnes, O. (1997) · The Lancet · doi:10.1016/s0140-6736(97)26040-x · Cited by 73
Fischer, S. A., Gupta, S., Leatham, E. W., Carrington, D., Mendall, M. A., Kaski, J. C., & Camm, A. J. (1998) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199806000-00003 · Cited by 41
Pathogenesis of atherosclerosis
Ylä‐Herttuala, S., Luoma, J., Kallionpää, H., et al. (1996) · Maturitas · doi:10.1016/0378-5122(96)01011-0 · Cited by 30
Inflammation in Acute Coronary Syndromes
Moreno, P., & Fallon, J. T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60463-8_19 · Cited by 12
Immune and Inflammatory Responses in the Human Atherosclerotic Plaque
van der Wal, A. C., de Boer, O. J., & Becker, A. E. (1997) · Springer eBooks · doi:10.1007/978-3-642-60463-8_18 · Cited by 3
Cited by
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Lockhart, P. B., Bolger, A. F., Papapanou, P. N., Osinbowale, O., Trevisan, M., Levison, M. E., Taubert, K. A., Newburger, J. W., Gornik, H. L., Gewitz, M. H., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31825719f3 · Cited by 1,038
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kühbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.579979 · Cited by 391
Metadata
- Authors
- Gurfinkel, E.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01
- Volume
- 20
- Issue
- 2
- Pages
- 121-127
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2097090404
- Cited by
- 304
- References
- 22
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.